Malvern enters grinding & dispersing market
Malvern Instruments (Malvern, UK) has entered a three year co-marketing agreement with Netzsch Grinding and Dispersing (Selb, Germany). The two companies serve shared markets including food, ceramics, pharmaceuticals, nano-technology applications, and surface coatings through to metal and mineral mining.
Malvern Instruments (Malvern, UK)has entered a three year co-marketingagreement with Netzsch Grindingand Dispersing (Selb, Germany).The two companies serve sharedmarkets including food, ceramics,pharmaceuticals, nano-technologyapplications, and surface coatings through to metal and mineral mining.
Particle characterization is becoming increasingly importantfor fine grinding to the submicron- or nanometer range becauseproduct properties often depend directly on particle size, accordingto Dimitrios Makrakis, Netzsch Grinding & Dispersing Business Unitmanaging director. He added: “The correct and reproducible analysisof particle size is a prerequisite for process optimization and qualitycontrol. As Malvern is a world-leading manufacturer in particleand materials characterization, we have the ideal partner to deliverthe best overall solution for both grinding technology and particlecharacterization and clients of both companies will benefit from thispartnership.”
Under the terms of the agreement, Malvern instrumentation will beinstalled in Netzsch demonstration and test laboratories in China, Brazil,Germany, Korea, India, and Russia. Customer materials in Netzschfacilities will be routinely tested using Malvern instrumentation, withMalvern staff available for consultation about analysing data. PaulWalker, Malvern’s managing director, said: “This cooperation betweentwo well-established, global companies provides real opportunitiesfor both of us to benefit from the collective expertise, experience, andmarket understanding that underpins each business.”
For more information please visit: www.malvern.com or http://www.netzsch.com/gd
This story originally appeared in The Column. Click here to view that issue.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.
